Involvement of the contact system of coagulation in the the human hepatoma cell line HepG2 by up to 75%. The decrease in protein secretion correlated with an equivalent pathogenesis of various inflammatory diseases is suggested by reduced plasma levels of factor XII (Hageman factor) and decrease of factor XII mRNA likely indicating a pretranslational control of factor XII gene expression by IL-6. Downregprekallikrein generally considered to result from activation of the contact system. However, in many of these diseases ulation of factor XII production by IL-6 in vitro parallelled that of transthyretin, a known negative acute-phase protein. patients develop an acute-phase response and, therefore, an alternative explanation for the decreased levels of factor XII Moreover, we show that, in patients developing an acutephase response after immunotherapy with IL-2, plasma levcould be the downregulation of factor XII gene expression in the liver as described for negative acute-phase proteins. els of factor XII correlate (r ! .76, P Ú .0001) with those of transthyretin. Taken together, these results suggest that We report here that interleukin-6 (IL-6), the principal cytokine mediating the synthesis of most acute-phase proteins factor XII behaves as a negative acute-phase protein.
circulating levels of FXIIa-and kallikrein-C1-inhibitor comrepeated at least three times, with duplicate incubations and duplicate plexes, which reflect activation of the contact system in vivo, determination of the secreted proteins.
are also low in most patients with sepsis. 7 Cytokines. Human recombinant IL-6 (rIL-6) produced in EscheMammalian liver responds to acute systemic injury by a richia coli was purified to homogeneity by gel filtration and ion dramatic change in the synthesis of various plasma proteins.
exchange high-performance liquid chromatography as described. 14, 15 This phenomenon is known as hepatic acute-phase response. 8, 9 The rate and amplitude of changes in plasma levels of the acute-phase proteins reflect the induction of their syn-
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thesis by various cytokines, such as interleukin-1b (IL-1b),
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Immunoassays. Proteins secreted in the culture media were quantified by sandwich-type ELISA. The ELISAs used to quantify fibrinogen and TTR were performed using a first polyclonal antibody for coating and a second polyclonal antibody labeled with biotin. The rabbit polyclonal antibodies used were separated from antiserum (Rabbit-antihuman fibrinogen and rabbit-anti-TTR; both from the Chemicals, Uppsala, Sweden) according to the manufacturer's inCulture medium was refreshed every 24 hours. FXII concentration in structions. FXII was measured using two monoclonal antibodies, culture media obtained after the third 24-hour period was measured both directed against the catalytic region of FXII, as previously by ELISA as described in the Materials and Methods. Results represent the mean Ô SD of three independent experiments. *P Ú .05 as described. 18 The amount of proteins present in the culture media compared with unstimulated cells.
was calculated by reference to a standard curve of pooled normal human plasma. By comparing dose-response curves of the latter with those of purified FXII, the pooled plasma was estimated to contain 35.3 { 2.9 mg of FXII per milliliter. The interassay coefficient of samples. A difference was considered significant, using a two-tailed variation of all assays was less than 10%.
P, at P õ .05. Results were corrected for cell number by assessing the total amount of RNA extracted from the flasks and were expressed as the RESULTS amount of protein secreted into the culture medium during 24 decrease resembled that of TTR. These results raised the question as to whether FXII might behave as a negative acute-phase protein during the acute-phase reaction in vivo. We therefore evaluated a possible correlation between plasma levels of FXII and TTR in patients treated with high doses of rIL-2 who develop an acute-phase reaction after high plasma levels of IL-6. Similarly to FXII, 21 TTR also significantly decreased during the treatment with rIL-2 (P õ .0001), and this decrease correlated with that of FXII (r Å .76, P õ .0001; Fig 4) .
DISCUSSION
The results presented here show that the synthesis of FXII in the human hepatoma cell line HepG2 is downregulated by IL-6. The hepatoma cell line HepG2 is very similar to hepatocytes in terms of biologic responsiveness [23] [24] [25] and is widely used as model system for studying the regulation of acute-phase protein synthesis in human liver.
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The decrease in FXII production by HepG2 cells was significant after 24 hours of rIL-6 stimulation and reached a nadir at 48 hours. Neither rIL1-b nor rTNFa had a significant effect on FXII levels. In fact, IL1-b and TNFa directly control the synthesis of only a limited subset of acute-phase proteins, 27, [30] [31] [32] [33] [34] [35] and their effect appears to be mediated, at least in part, by the induction of IL-6 synthesis.
10,11,36-38 In vitro studies using hepatocyte cultures and correlations of serum IL-6 concentrations with acute-phase protein levels in various inflammatory states in vivo indicate that IL-6 which include albumin, a 2 -HS-glycoprotein, TTR, transferrin, and retinol-binding protein, has been observed. Decreased levels have generally been thought to be due to transfer to the extravascular space or to increased metabothe presence of rIL-6 (data not shown). As control for negalism; nevertheless, recent studies indicate that IL-1, TNF, tive acute-phase protein, we evaluated the production of and IL-6 are all capable of decreasing transcription of genes TTR, whose levels decreased by 37% after 24 hours and by for albumin 29, [39] [40] [41] and that IL-6 decreases transcription of the 70% after 72 hours after rIL-6 stimulation of HepG2 cells TTR gene in HepG2 cells.
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( Fig 2B) . Although TTR levels were generally higher in FXII and TTR levels were decreased in the culture media culture media from cells maintained without FCS, the extent of rIL-6-stimulated HepG2 cells cultured either in the presof the decrease induced by rIL-6 was comparable with that ence or in the absence of FCS, thus ruling out the possibility observed in cells cultured in the presence of 10% FCS (Fig that the observed decreases were due to negative regulators 2B). present in the FCS. However, higher levels of FXII protein FXII mRNA levels in HepG2 cells. Northern blot analyand specific mRNA as well as of TTR were found in the sis showed that FXII mRNA levels were decreased by 23% medium from cells cultured without FCS especially after 72 after 24 hours and by 66.5% after 48 and 72 hours of rILhours. This my have been due to the presence of IL-6 in the 6 stimulation (Fig 3A and B ). An increase of FXII mRNA FCS, but the finding that this FCS was negative in a bioassay was observed at 72 hours in unstimulated HepG2 cells culfor IL-6, ie, the B9 assay, 16 allowed us to exclude this possitured without FCS.
bility. Possibly, the higher levels of proteins and mRNA FXII and TTR levels in IL-2-treated patients. The exfound in the FCS-free cultures, compared with the FCS culperiments described above showed that rIL-6 downregulated FXII production by a human hepatoma cell line and that the tures, reflected either the presence of unidentified negative regulators in the FCS or a higher expression of liver-specific genes by nonproliferating hepatoma cells.
Modulation of acute-phase gene expression by cytokines has been shown to be mostly at pretranslational level. 9, 10, 31, 39, 42, 43 The quantitative changes in secreted FXII and steady-state mRNA levels during rIL-6 stimulation were comparable, suggesting that rIL-6 control on FXII synthesis was indeed at a pretranslational level. However, more experiments are needed to clarify whether the inhibitory effect of IL-6 on accumulation of FXII transcripts is mediated by a decrease of FXII gene transcriptional rate and/or a decrease in FXII mRNA stability. Recently, the hepatocyte nuclear factor-3 (HNF-3) proteins have been shown to regulate the transcription of a number of negative acute-phase genes, such as albumin, transferrin, and TTR, [44] [45] [46] and it has been proposed that the decreased HNF-3a expression during the acute-phase response may, indeed, mediate the reduced tran- HNF-3 proteins (Fig 5) of TTR suggests that FXII may act as a negative acute-phase J Lab Clin Med 115: 463, 1990 protein during the acute-phase reaction. This was corrobo- to albumin. 21 We show here that the FXII decrease correlated 
